{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:16:51Z","timestamp":1791296211087,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Schizophrenia Research Institute"},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001773","name":"University of New South Wales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012769","name":"Neuroscience Research Australia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012769","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.bbi.2014.05.011","type":"journal-article","created":{"date-parts":[[2014,5,27]],"date-time":"2014-05-27T16:49:50Z","timestamp":1401209390000},"page":"173-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Effect of maternal immune activation on the kynurenine pathway in preadolescent rat offspring and on MK801-induced hyperlocomotion in adulthood: Amelioration by COX-2 inhibition"],"prefix":"10.1016","volume":"41","author":[{"given":"Katerina","family":"Zavitsanou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chai K.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tertia","family":"Purves-Tyson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Karl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kassiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel D.","family":"Banister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles J.","family":"Guillemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia Shannon","family":"Weickert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2014.05.011_b0045","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.bbi.2010.03.005","article-title":"Effects of prenatal infection on brain development and behavior: a review of findings from animal models","volume":"24","author":"Boksa","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2014.05.011_b0035","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1176\/appi.ajp.2008.08010089","article-title":"Prenatal exposure to maternal infection and executive dysfunction in adult schizophrenia","volume":"166","author":"Brown","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2014.05.011_b0280","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0306-4522(89)90012-2","article-title":"Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats","volume":"28","author":"Carboni","year":"1989","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbi.2014.05.011_b0310","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jnr.10192","article-title":"Inhibition of COX-2 reduces the age-dependent increase of hippocampal inflammatory markers, corticosterone secretion, and behavioral impairments in the rat","volume":"68","author":"Casolini","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbi.2014.05.011_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/IJTR.S2097","article-title":"Kynurenine pathway metabolites in humans: disease and healthy States","volume":"2","author":"Chen","year":"2009","journal-title":"Int. J. Tryptophan Res.: IJTR"},{"key":"10.1016\/j.bbi.2014.05.011_b0195","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/schbul\/sbl033","article-title":"Elevations of endogenous kynurenic acid produce spatial working memory deficits","volume":"33","author":"Chess","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2014.05.011_b0220","doi-asserted-by":"crossref","first-page":"451865","DOI":"10.5402\/2012\/451865","article-title":"Synergistic effect between maternal infection and adolescent cannabinoid exposure on serotonin 5HT1A receptor binding in the hippocampus: testing the \u201cTwo Hit\u201d hypothesis for the development of schizophrenia","volume":"2012","author":"Dalton","year":"2012","journal-title":"ISRN Psychiatry"},{"key":"10.1016\/j.bbi.2014.05.011_b0015","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1017\/S1461145710001410","article-title":"Understanding the role of inflammatory-related pathways in the pathophysiology and treatment of psychiatric disorders: evidence from human peripheral studies and CNS studies","volume":"14","author":"Dean","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2014.05.011_b0180","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1365-201X.2002.00962.x","article-title":"Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid","volume":"175","author":"Erhardt","year":"2002","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.bbi.2014.05.011_b0165","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0304-3940(01)02242-X","article-title":"Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia","volume":"313","author":"Erhardt","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbi.2014.05.011_b0190","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.biopsych.2004.06.006","article-title":"Endogenous kynurenic acid disrupts prepulse inhibition","volume":"56","author":"Erhardt","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2014.05.011_b0115","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/npp.2012.248","article-title":"Connecting inflammation with glutamate agonism in suicidality","volume":"38","author":"Erhardt","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2014.05.011_b0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/mp.2012.199","article-title":"Markers of inflammation in the prefrontal cortex of individuals with schizophrenia","volume":"18","author":"Fillman","year":"2013","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.bbi.2014.05.011_b0135","doi-asserted-by":"crossref","first-page":"e365","DOI":"10.1038\/tp.2014.8","article-title":"Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder","volume":"4","author":"Fillman","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbi.2014.05.011_b0105","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.biopsych.2013.01.001","article-title":"Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia","volume":"73","author":"Fineberg","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2014.05.011_b0285","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0028-3908(86)90246-7","article-title":"Effects of phencyclidine on ventral tegmental A10 dopamine neurons in the rat","volume":"25","author":"French","year":"1986","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2014.05.011_b0140","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","article-title":"Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism","volume":"56","author":"Fukui","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2014.05.011_b0235","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF00964611","article-title":"L-kynurenine: its synthesis and possible regulatory function in brain","volume":"5","author":"Gal","year":"1980","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbi.2014.05.011_b0090","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbi.2012.07.008","article-title":"Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development","volume":"31","author":"Garay","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2014.05.011_b0240","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","article-title":"Quinolinic acid, the inescapable neurotoxin","volume":"279","author":"Guillemin","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.bbi.2014.05.011_b0145","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1471-4159.2001.00498.x","article-title":"Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection","volume":"78","author":"Guillemin","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2014.05.011_b0150","doi-asserted-by":"crossref","first-page":"12884","DOI":"10.1523\/JNEUROSCI.4101-07.2007","article-title":"Characterization of the kynurenine pathway in human neurons","volume":"27","author":"Guillemin","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2014.05.011_b0005","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature09552","article-title":"Rethinking schizophrenia","volume":"468","author":"Insel","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2014.05.011_b0265","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2014.05.011_b0085","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.schres.2011.06.018","article-title":"Microglial activation in a neuroinflammational animal model of schizophrenia \u2013 a pilot study","volume":"131","author":"Juckel","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2014.05.011_b0260","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF00216006","article-title":"Provocative tests with psychostimulant drugs in schizophrenia","volume":"91","author":"Lieberman","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbi.2014.05.011_b0225","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4137\/IJTR.S11789","article-title":"Characterization of the kynurenine pathway and quinolinic acid production in macaque macrophages","volume":"6","author":"Lim","year":"2013","journal-title":"Int. J. Tryptophan Res.: IJTR"},{"key":"10.1016\/j.bbi.2014.05.011_b0040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/archpsyc.1988.01800260109013","article-title":"Adult schizophrenia following prenatal exposure to an influenza epidemic","volume":"45","author":"Mednick","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbi.2014.05.011_b0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pnpbp.2011.11.003","article-title":"Developmental neuroinflammation and schizophrenia","volume":"42","author":"Meyer","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2014.05.011_b0270","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bbr.2008.12.022","article-title":"Neural basis of psychosis-related behaviour in the infection model of schizophrenia","volume":"204","author":"Meyer","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbi.2014.05.011_b0050","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.pneurobio.2009.10.018","article-title":"Epidemiology-driven neurodevelopmental animal models of schizophrenia","volume":"90","author":"Meyer","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbi.2014.05.011_b0255","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbi.2007.09.012","article-title":"Adult brain and behavioral pathological markers of prenatal immune challenge during early\/middle and late fetal development in mice","volume":"22","author":"Meyer","year":"2008","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2014.05.011_b0275","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/schbul\/sbn131","article-title":"Evaluating early preventive antipsychotic and antidepressant drug treatment in an infection-based neurodevelopmental mouse model of schizophrenia","volume":"36","author":"Meyer","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2014.05.011_b0290","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0361-9230(95)02144-2","article-title":"Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats","volume":"40","author":"Miller","year":"1996","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbi.2014.05.011_b0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pnpbp.2012.03.010","article-title":"Prenatal inflammation and neurodevelopment in schizophrenia: a review of human studies","volume":"42","author":"Miller","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2014.05.011_b0245","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2014.05.011_b0250","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF03033242","article-title":"Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission","volume":"10","author":"Muller","year":"2006","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bbi.2014.05.011_b0300","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1176\/appi.ajp.159.6.1029","article-title":"Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia","volume":"159","author":"Muller","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2014.05.011_b0030","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.schres.2010.04.015","article-title":"Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment","volume":"121","author":"Muller","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2014.05.011_b0215","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.2174\/138920112800784826","article-title":"Immunological treatment options for schizophrenia","volume":"13","author":"Muller","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.bbi.2014.05.011_b0175","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.bbi.2011.05.005","article-title":"Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naive and medication-free schizophrenic patients","volume":"25","author":"Myint","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2014.05.011_b0170","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.schres.2005.07.013","article-title":"Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia","volume":"80","author":"Nilsson","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2014.05.011_b0100","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/schbul\/sbr178","article-title":"Priming of metabolic dysfunctions by prenatal immune activation in mice: relevance to schizophrenia","volume":"39","author":"Pacheco-Lopez","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2014.05.011_b0075","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.biopsych.2009.07.005","article-title":"Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia","volume":"66","author":"Piontkewitz","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2014.05.011_b0065","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/schbul\/sbq040","article-title":"Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia","volume":"37","author":"Piontkewitz","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2014.05.011_b0070","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.neuropharm.2011.04.019","article-title":"Tracing the development of psychosis and its prevention: what can be learned from animal models","volume":"62","author":"Piontkewitz","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2014.05.011_b0205","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bbi.2011.11.004","article-title":"Effects of risperidone treatment in adolescence on hippocampal neurogenesis, parvalbumin expression, and vascularization following prenatal immune activation in rats","volume":"26","author":"Piontkewitz","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2014.05.011_b0200","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1111\/j.1460-9568.2012.08064.x","article-title":"Pre- and postnatal exposure to kynurenine causes cognitive deficits in adulthood","volume":"35","author":"Pocivavsek","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbi.2014.05.011_b0305","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.biopsych.2005.02.024","article-title":"Celecoxib augmentation of continuously ill patients with schizophrenia","volume":"57","author":"Rapaport","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2014.05.011_b0155","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/schbul\/sbq112","article-title":"Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia","volume":"37","author":"Sathyasaikumar","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2014.05.011_b0160","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0006-3223(01)01078-2","article-title":"Increased cortical kynurenate content in schizophrenia","volume":"50","author":"Schwarcz","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2014.05.011_b0120","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbi.2014.05.011_b0210","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00702-004-0231-y","article-title":"Prostaglandin-mediated control of rat brain kynurenic acid synthesis \u2013 opposite actions by COX-1 and COX-2 isoforms","volume":"112","author":"Schwieler","year":"2005","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbi.2014.05.011_b0185","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1038\/sj.npp.1300188","article-title":"Micromolar brain levels of kynurenic acid are associated with a disruption of auditory sensory gating in the rat","volume":"28","author":"Shepard","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2014.05.011_b0230","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/abio.2001.5490","article-title":"Concurrent quantification of quinolinic, picolinic, and nicotinic acids using electron-capture negative-ion gas chromatography\u2013mass spectrometry","volume":"301","author":"Smythe","year":"2002","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbi.2014.05.011_b0125","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/bph.12230","article-title":"The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders","volume":"169","author":"Stone","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbi.2014.05.011_b0130","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1742-4658.2012.08487.x","article-title":"Kynurenine pathway inhibition as a therapeutic strategy for neuroprotection","volume":"279","author":"Stone","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.bbi.2014.05.011_b0010","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/archpsyc.1987.01800190080012","article-title":"Implications of normal brain development for the pathogenesis of schizophrenia","volume":"44","author":"Weinberger","year":"1987","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbi.2014.05.011_b0095","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuropharm.2013.05.012","article-title":"Altered GSK3beta signaling in an infection-based mouse model of developmental neuropsychiatric disease","volume":"73","author":"Willi","year":"2013","journal-title":"Neuropharmacology"},{"issue":"Suppl. 2","key":"10.1016\/j.bbi.2014.05.011_b0295","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1093\/schbul\/sbt157","article-title":"Targeting kynurenine aminotransferase II in psychiatric diseases: promising effects of an orally active enzyme inhibitor","volume":"40","author":"Wu","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2014.05.011_b0060","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jpsychires.2004.08.008","article-title":"Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring","volume":"39","author":"Zuckerman","year":"2005","journal-title":"J. Psychiatry Res."},{"key":"10.1016\/j.bbi.2014.05.011_b0055","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/sj.npp.1300248","article-title":"Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia","volume":"28","author":"Zuckerman","year":"2003","journal-title":"Neuropsychopharmacology"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159114001330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159114001330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:37:00Z","timestamp":1760168220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159114001330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":62,"alternative-id":["S0889159114001330"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2014.05.011","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of maternal immune activation on the kynurenine pathway in preadolescent rat offspring and on MK801-induced hyperlocomotion in adulthood: Amelioration by COX-2 inhibition","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2014.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}